DanCann Pharma A/S publishes Q3-2023 report
COPENHAGEN, Denmark, 30 November 2023 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the "Company"), a Danish company powered by cannabinoids, hereby announce that the Company has published its report for the third quarter of 2023. The Q3-2023 report is available as an attached document to this press release and at www.dancann.com.Summary: Group key figures Q3 2023 DKK1000 01/01/23 01/01/22 01/07/23 01/07/22 01/01/22 – 31/12/22 – 30/09/23 -30/09/22 - 30/09/23 - 30/09/22 Net sales 4,462 3,606 1,625 1,569 5,707